课题基金 / 基金详情

Behavioral Economics and Intervention Science

Behavioral Economics and Intervention Science
行为经济学和干预科学
批准号:
10491311
负责人:
STACEY C SIGMON
金额:
$28.72万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-15 至 2024-07-31

项目摘要

项目成果

STACEY C SIGMON的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 核心B:行为经济学和干预科学(BEIS)核心 佛蒙特州行为与健康中心(VCBH)致力于研究 个人行为模式以及慢性病和过早死亡的风险。的总目标 行为经济学和干预科学(BEIS)的核心是为VCBH调查人员提供科学的 以及三个关键领域的技术专长和研究基础设施。第一,核心的决策 该模块提供行为选择和决策研究方面的专业知识,重点是 研究核心认知过程(例如,执行功能)和决策偏差, 增加了对危险健康行为的脆弱性,破坏了对干预措施的反应。为此,我们 我已经建立了BEIS核心评估服务,其中一个训练有素的,移动的评估团队 管理一个全面的电池评估多个领域的执行功能和偏见的决定 包括注意力、工作记忆、抑制、错误监控和对 奖励的激励、时间、概率和社会折扣。我们定制评估组合 以便它们适合于个别研究中的具体目标和调查对象,同时还 希望促进和支持跨学科行为经济学的主题相关研究。第二、 BEIS干预科学模块在设计和实施方面提供独特的专业知识, 以激励为基础的干预措施以及其他行为和药物干预措施,以促进与健康有关的行为 变化我们协助研究人员开发和定制干预措施,以独特的特点, 人口和有针对性的风险行为。我们还拥有将技术与 这些干预措施可以增加其可获得性,同时也有可能降低治疗费用。最后我们 核心的经济建模模块提供援助与干预措施和健康的计量经济学分析 成果,包括帮助筹备和开展成本效益、成本效用和成本效益评估 分析。这包括协助计算与治疗结果相关的成本抵消(例如, 获得的每寿命年成本、获得的每质量调整寿命年成本、每美元投资的净节省以及美元 预防的每例住院病例节省的费用)。BEIS核心及其专用服务模块 将继续提供专门知识和评估、干预措施和技术, 经济建模中心的研究提出了在VCBH和整个UVM校园。
英文摘要
PROJECT SUMMARY CORE B: Behavioral Economics and Intervention Science (BEIS) Core The Vermont Center on Behavior and Health (VCBH) is dedicated to researching relationships between personal behavior patterns and risk for chronic disease and premature death. The overarching purpose of the Behavioral Economics and Intervention Sciences (BEIS) Core is to provide VCBH investigators with scientific and technical expertise and research infrastructure in three key areas. First, our Core's Decision-Making Module provides expertise in the study of behavioral choice and decision making, with an emphasis on investigating the core cognitive processes (e.g., executive functions) and biases in decision making that may increase vulnerability to risky health behaviors and undermine response to interventions. Toward this end, we have established the BEIS Core Assessment Service, wherein a highly-trained, mobile assessment team administers a comprehensive battery evaluating multiple domains of executive function and biased decision making that includes measures of attention, working memory, inhibition, error monitoring, and sensitivity to incentives, and temporal, probability, and social discounting of rewards. We customize assessment batteries so that they are tailored to the specific aims and population under investigation in individual studies, while also looking to facilitate and support thematically related research in behavioral economics across studies. Second, the BEIS Intervention Sciences Module provides unique expertise in the design and implementation of incentive-based and other behavioral and pharmacological interventions to promote health-related behavior change. We assist investigators in developing and tailoring interventions to the unique characteristics of the population and targeted risk behavior. We also have center expertise in the integration of technology with these interventions to increase their accessibility, while also potentially lowering treatment costs. Finally, our Core's Economic Modeling Module provides assistance with econometric analyses of interventions and health outcomes, including help with the preparation for and conduct of cost-effectiveness, cost-utility and cost-benefit analyses. This includes assistance in calculating the cost-offset associated with treatment outcomes (e.g., cost per life year gained, cost per quality-adjusted life years gained, net savings per dollar invested, and dollars saved per hospitalization case prevented). Taken together, the BEIS Core and its dedicated service modules will continue to provide the expertise and access to the assessments, interventions and technology, and economic modeling central to the research proposed within the VCBH and also across the UVM campus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE B: Behavioral Economics and Intervention Science (BEIS) Core
Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluation
Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluation
Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluation
海外基金